|
Status |
Public on Jan 05, 2018 |
Title |
Targeting the vulnerability of RB tumor suppressor loss in triple negative breast cancer |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
Approximately 30% of TNBCs exhibit loss of function of the RB tumor suppressor. The study used RNA sequencing to profile RB-proficient and RB-deficient TNBC cases that were defined based on immunostaining for RB and p16ink4a. The analyses revealed that RB-deficient TNBC cases express elevated levels of DNA replication and mitotic genes that could serve as the basis for increased sensitivity to drugs targeting cell cycle checkpoints.
|
|
|
Overall design |
The study compared normal tissue, RB-positive, and RB-deficient TNBC. RNA sequencing was utilized to define differentially expressed genes.
|
|
|
Contributor(s) |
Witkiewicz A, Knudsen ES |
Citation(s) |
29386107 |
Submission date |
Jan 04, 2018 |
Last update date |
Feb 10, 2020 |
Contact name |
Adam David Grant |
E-mail(s) |
adglink@email.arizona.edu
|
Phone |
801-471-6751
|
Organization name |
University of Arizona
|
Department |
Cancer Biology
|
Lab |
Erik Knudsen
|
Street address |
3760 E. Felix Blvd
|
City |
Tucson |
State/province |
Arizona |
ZIP/Postal code |
85706 |
Country |
USA |
|
|
Platforms (1) |
GPL13393 |
AB SOLiD 4 System (Homo sapiens) |
|
Samples (13)
|
|
Relations |
BioProject |
PRJNA428502 |
SRA |
SRP130931 |